Karyopharm Therapeutics (KPTI)
(Delayed Data from NSDQ)
$1.06 USD
0.00 (0.00%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.05 -0.01 (-0.94%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-0.33 | 0.00% |
Earnings Summary
For their last quarter, Karyopharm Therapeutics (KPTI) reported earnings of -$0.36 per share, missing the Zacks Consensus Estimate of -$0.29 per share. This reflects a negative earnings surprise of 24.14%. Look out for KPTI's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.33 per share, reflecting a year-over-year decrease of 10%.
Earnings History
Price & Consensus
Zacks News for KPTI
Xencor (XNCR) Surges 13.4%: Is This an Indication of Further Gains?
KPTI: What are Zacks experts saying now?
Zacks Private Portfolio Services